Scroll for more
Innovative solutions using next generation CRISPR-Cas12a technology
Operating at the forefront of gene editing.
Our structure-based rational design that stems from structural insights* on CRISPR-Cas12a system allows us to manipulate and optimize its activity for therapeutic purposes.
*The foundational structural analysis of the CRISPR-Cas12a system was performed in the Montoya Research Group within the Protein Structure & Function Program at the University of Copenhagen, Novo Nordisk Foundation Center for Protein Research. (Stella et al., 2017 Nature, Stella et al., 2018 Cell).
TeamMeet the entire team
Nkerorema Djodji Damas
Johanne Bay Mogensen
Emil Christian Fischer
Bhakti Jayant Vyas